Alzheimer

Ivan Pedley, 92: the doyen of British senior table tennis is still going strong!

In the world of sport, age is often seen as a barrier to performance. Yet some enthusiasts are proving that the pleasure of the game and the benefits of physical activity know no age limits. Such is the case of Ivan Pedley, a 92-year-old British ping-pong doyen, who continues to play with exemplary assiduity. At […]

Ivan Pedley, 92: the doyen of British senior table tennis is still going strong! Read More »

NeuroClues - Medtech

neuroClues® raises 5 million Euros and prepares to launch its measurement solution to diagnose neurological diseases such as Parkinson’s more quickly.

@neuroClues raises 5 million Euros and prepares to launch its measurement solution to diagnose @neurological diseases

neuroClues® raises 5 million Euros and prepares to launch its measurement solution to diagnose neurological diseases such as Parkinson’s more quickly. Read More »

Light4life : a pivotal clinical study by REGEnLIFE to evaluate the therapeutic efficacy of its photomedical technology in Alzheimer’s disease

During the 15th edition of the CTAD (Clinical Trials on Alzheimer’s Disease) taking place from November 29 to December 2 of 2022 in San Francisco, USA, REGEnLIFE, a French company specialized in the research and development of innovative technologies in photo-medicine for the prevention and treatment of neurodegenerative diseases, presented the concept of its next

Light4life : a pivotal clinical study by REGEnLIFE to evaluate the therapeutic efficacy of its photomedical technology in Alzheimer’s disease Read More »

Scroll to Top